Chang Gung Medical Foundation, Taiwan

CompanyTaiwanFounded 1973

Chang Gung Medical Foundation, Taiwan develops one asset, in phase 2 (DAOIB in long COVID). Mostly small molecule; based in Taiwan, founded in 1973.

1
Asset
Furthest stage: Phase 2; 81
Trials: 1
Signal

Pipeline

1

DAOIB
Phase 2, Small molecule, long COVID

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials105
Signals1
Similar companies6

Papers

Lipid Indicators and Low Bone Mass Among Taiwanese Adults: A Cross-Sectional Association Study
Nutrients, Oct 27, 2026
Longitudinal patterns and determinants of lipoprotein(a) variability: a 15-year multi-center study
ESC Congress 2026 abstract, Oct 26, 2026
Self-powered bioelectronics for peripheral nerve regeneration: Electroactive materials, energy transduction, and therapeutic mechanisms
Materials today. Bio, Oct 25, 2026
Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
Liver international : official journal of the International Association for the Study of the Liver, Oct 25, 2026
The relationship between 5α-reductase inhibitors and the presence of following open angle glaucoma: a TriNetX cohort study
International journal of medical sciences, Oct 23, 2026
Artificial intelligence in diabetic retinopathy: From deep learning to foundation models, clinical translation, and real-world deployment
Survey of ophthalmology, Oct 23, 2026
GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation
Scientific reports, Oct 21, 2026
Diabetes drugs linked to fewer harms but more genital infections
Diabetic medicine : a journal of the British Diabetic Association, Oct 19, 2026
The Association Between Serum Vitamin D and Gait Speed in a Middle-Aged and Older Taiwanese Population: A Community-Based Cross-Sectional Study
Rejuvenation research, Oct 12, 2026
Sex- and age-specific associations between metabolic phenotypes and brachial-ankle pulse wave velocity in adults: a cross-sectional study
Frontiers in medicine, Oct 11, 2026
Boronate ester-crosslinked GelMA composite bioink for 3D bioprinting of cell-laden corneal stroma and in vivo evaluation in rabbits
International Journal of Bioprinting, Oct 8, 2026
Sex-specific associations of urinary N-acetyl- β -D-glucosaminidase with arterial stiffness
Frontiers in medicine, Oct 2, 2026
Risk factors for recurrent urinary tract infection after SGLT2 inhibitor reinitiation in type 2 diabetes
Endocrine, Sep 29, 2026
Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes
Nature communications, Sep 24, 2026
A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan
Obesity research & clinical practice, Sep 15, 2026
Taiwan joint consensus on the management of osteoporosis in patients with diabetes
Journal of the Formosan Medical Association = Taiwan yi zhi, Sep 9, 2026
Dementia Risk After Glaucoma Surgery and Medical Therapy: A Multicentre Real-World Cohort Study
International journal of geriatric psychiatry, Sep 4, 2026
Lifestyle behaviors as Effect Modifiers in the Association Between Oral Health and Carotid Artery Calcification: A Cross-Sectional Study
International dental journal, Sep 3, 2026
The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study
Atherosclerosis, Sep 3, 2026
Association of sleep duration, lifestyle habits, and motor vehicle accident mortality-A prospective cohort study
Sleep health, Aug 31, 2026